Literature DB >> 179345

Computerized tomography (CT) in acute head trauma.

J Merino-deVillasante, J M Taveras.   

Abstract

The retrospective evaluation of 100 cases of head trauma that were subjected to computerized tomography (CT) leads to the following conclusions: (1) Computerized tomography and plain skull survey, should be the first neuroradiological procedures to perform. (2) Angiography may be carried out after computerized tomography when necessary, but as proved by this series, it will be needed in a relatively small number of cases. These include patients with technically limited CT scans or those in whom the possibility of an associated vascular lesion of the cervical or intracranial vessel is clinically suspected. (3) It is essential to obtain CT scans of the best possible quality. Sedation will be required in many instances, but this is considered worth doing because a normal CT scan, without significant technical limitations, will exclude the presence of lesions requiring prompt surgical intervention. Those patients who require surgery will need general anesthesia under any circumstances. (4) There is generally a direct relationship between the severity of clinical presentation and the CT demonstration of the abnormality responsible for the clinical status. Seventy percent of the patients clinically diagnosed as contusion had positive CT scans, and for all practical purposes, 100 percent of patients having trauma more severe than our Group III (contusion) had abnormal CT scans. Likewise, the number and intensity of tissue abnormalities on CT scans increase proportionately with the severity of the clinical signs and symptons. (5) It is foreseen that, with the advent of faster computerized tomographic scanners, the usefulness of this method will increase further, owing to a reduction in the total examination time and the lessened requirement for sedation.

Entities:  

Mesh:

Year:  1976        PMID: 179345     DOI: 10.2214/ajr.126.4.765

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

1.  Hypodense bubbles in acute extradural haematomas following venous sinus tear. A CT scan appearance.

Authors:  C P Chee; Z A Habib
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Intraventricular hemorrhage originating from choroid plexus angioma in a road accident victim.

Authors:  A Gross; B Próchnicka
Journal:  Z Rechtsmed       Date:  1989

3.  A case of traumatic periventricular hematoma evaluated by CT in a child.

Authors:  H Kuchiwaki; S Kobayashi
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

4.  Computerised tomography after recent severe head injury in patients without acute intracranial haematoma.

Authors:  J Snoek; B Jennett; J H Adams; D I Graham; D Doyle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-03       Impact factor: 10.154

5.  Delayed traumatic intracranial hematomas--clinical study of seven years.

Authors:  C Sprick; M Bettag; W J Bock
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

6.  Enlargement of intracerebral haematomas following surgical removal of epidural haematomas.

Authors:  M Taneda; T Irino
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

7.  Post-traumatic hydrocephalus in patients with severe head injury.

Authors:  P R Kishore; M H Lipper; J D Miller; A K Girevendulis; D P Becker; F S Vines
Journal:  Neuroradiology       Date:  1978       Impact factor: 2.804

8.  Prognostic value of CT in head-injury coma.

Authors:  L Gozzoli; A Cecchini; F Rognone; R Dionigi; P Geraci
Journal:  Ital J Neurol Sci       Date:  1983-06

9.  Posttraumatic intraventricular haemorrhages.

Authors:  M Zuccarello; R Iavicoli; K Pardatscher; P Cervellini; D Fiore; S Mingrino; M Gerosa
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

10.  Secondary intraventricular haemorrhage in blunt head trauma.

Authors:  J Piek; W J Bock
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.